Op deze pagina vindt u het laatste nieuws uit de wereld van klinisch onderzoek!
Nieuwsfeed
- The latest from Pharmalot
- Steeds meer tandartspraktijken opgekocht door keten
- Drug labeling authority, UDI program reviewed by Harvard-based researchers
- FDA issues new COVID-19 master protocol guidance
- MDCG prods COVID diagnostic makers to assess variants
- FDA to CytoDyn: Those 2 Covid trials you keep touting both failed on all endpoints and your subgroup analysis doesn't help. Are we clear now?
- Biotech: Where are we now?
- Jobs in Oncology/Hematology
- Public Web Conference to Provide Progress Update on ICH E6 Guideline for Good Clinical Practice - 05/18/2021 - 05/19/2021
- CDC veteran Anne Schuchat to resign; abandoned Trump order on bioeconomy highlights path forward for Biden
- Prullenbakvaccin.nl al op miljoen hits per dag
- Temporada de huracanes: Prepárese
- Sample formats for Form FDA 356h_2011
- Statement on Leronlimab
- Recall Expansion of Durisan Non-Alcohol Hand Sanitizer
- ACRPtv—Spotlight On… ACRP’s Diversity Advisory Council
- FDA Voices on Policy
- FDA Voices
- Durisan Hand Sanitizer Recall Due to Microbial Contamination
- Durisan Announces a Voluntary Recall Expansion of its Antimicrobial Hand Sanitizer
- Veel onduidelijk over mondkapjesdeal Van Lienden
- What's New Related to Drugs
- Investigational New Drug Applications (INDs) for CBER-Regulated Products
- Drug Supply Chain Security Act pilot project program and enhanced drug distribution security - 12/08/2020 - 12/09/2020
- Pandemic Influenza Information
- Recon: Sanofi, GKS report positive interim results for COVID shot; Regeneron resumes lymphoma trials after hold lifted
- User Fee Lists
- EU IVDR countdown: Opportunities await, but concerns linger over notified bodies
- Generic Drug Facilities, Sites and Organization Lists
- Competitive Generic Therapy Approvals
- Blood Products Advisory Committee June 22, 2018 Meeting Announcement - 06/22/2018 - 06/22/2018
- SCOTUS declines to review Enbrel biosimilar case, teeing up 30+ years of exclusivity and $20B more for Amgen’s blockbuster
- Drug Safety and Availability
- Overleg commissie Kamer met juristen over specialisten
- Advancing FDA’s Mission by Targeting Key Areas for Regulatory Science Investment and Innovation
- Euro Convergence: Academic clinics should establish risk management programs for ATMP development
- Novel Drug Approvals for 2021
- Manufacturing, Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers
- Blood Products Advisory Committee July 18-19, 2018 Meeting Announcement - 07/17/2018 - 07/18/2018
- Places still available for our free online conference
- Onderzoek: ontzenuwen mythes belangrijk voor vertrouwen in vaccin
- Johnson & Johnson donates Ebola vaccine amid new outbreak; Ji Xing promises more than $127M for Milestone's nasal spray for rapid heart rate
- Charles River keeps adding on to its CDMO arm, snatching up a viral vector player for a tidy $350M
- How to manufacture Covid-19 vaccines without the help of J&J, Pfizer or Moderna? Biolyse sees the difficulties up close
- Advies jeugdzorg: maak hulpvraag kind leidend
- Incyte keeps rolling on topical cream for JAK inhibitor, passing two PhIII tests in vitiligo
- Public Notification: “1 Day Diet” Contains Hidden Drug Ingredient
- ‘Snelle afname coronapatiënten goed nieuws voor reguliere zorg’
- FDA In Brief: FDA Provides Guidance on Master Protocols for Evaluating Prevention, Treatment Options for COVID-19
- EMA: Pfizer-vaccin mag langer in koelkast bewaard